Based on this cell culture model, we have demonstrated that drug-resistant NB cancer cells develop an increased malignant phenotype as evidenced by enhanced adhesion to vascular endothelial cells, accompanied by significant downregulation of the adhesion receptor NCAM. The gene discussed is NCAM1; the disease is neuroblastoma.